Identifying therapeutic gene targets is essential for advancing personalised medicine and addressing the genetic basis o...
South Korea-based startup Lunit, a leading provider of artificial intelligence (AI)-powered solutions for cancer diagnos...
SK Chemicals, which developed Korea's first herbal medicine product for osteoarthritis, Joins, has expanded its pai...
Taiwan-based Formosa Group Executive Committee member and Chairman Sandy Wang, who leads the group's bio and eco-friendl...
Adipose tissues, which serve as fat reserves, have been recognised as an endocrine organ. The three-dimensional (3D) bio...
Degrader-antibody conjugates (DACs) represent a natural evolution in targeted precision medicines for oncology and other...
South Korea-based SK bioscience had received prior notification from the Pan American Health Organization (PAHO), a spec...
South Korea-based startup Lunit, a leading provider of artificial intelligence (AI)-powered solutions for cancer diagnos...
Olympus Corporation of Asia Pacific (APAC) has announced a milestone for its iTind device with expanded availability acr...
A Leading Center for Biopharma Excellence BIX has established itself as a must-attend event for professionals across th...
The future of biopharmaceutical innovation will take centr- stage at BIOPLUS-INTERPHEX KOREA (BIX) 2025, returning on Oc...
China-based WuXi XDC Cayman Inc., a leading global CRDMO (Contract Research, Development, and Manufacturing Organization...
The International Vaccine Institute (IVI) has opened its new Biorepository, a global centre for biological resources, at...
South Korea-based Coreline Soft, a global leader in artificial intelligence (AI)-based medical solutions, has annou...
Brexogen, a leading biotechnology company specialising in exosome-based therapeutics, has announced a technology transfe...
Novotech, a global full-service clinical Contract Research Organisation (CRO) that partners with biotech and small to mi...
Taiwan-based startup Health2Sync, a leading provider of digital therapeutics solutions for chronic diseases, is experien...
SK Bioscience reported strong revenue growth in Q4 2024, primarily driven by the consolidation of IDT Biologika, expansi...
